NLRP3 expression depends on the signal transducer STAT5, and STAT5 is constitutively active in CTCL lesions beginning in the early stages of the disease (20). This evidence concerns the gene NLRP3 and primary cutaneous T-cell non-Hodgkin lymphoma.